Axovant Fiscal Q3 Earnings Snapshot

SIOXDelisted Stock  USD 0.40  0.01  2.56%   
Slightly above 55% of Sio Gene's investors are presently thinking to get in. The analysis of current outlook of investing in Sio Gene Therapies suggests that some traders are interested regarding Sio Gene's prospects. Sio Gene's investing sentiment can be driven by a variety of factors including economic data, Sio Gene's earnings reports, geopolitical events, and overall market trends.
  
NEW YORK NEW YORK Axovant Sciences Ltd. on Tuesday reported a...

Read at houstonchronicle.com
news
  

Sio Gene Fundamental Analysis

We analyze Sio Gene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sio Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sio Gene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

Sio Gene is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Sio Gene Therapies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sio Gene stock to make a market-neutral strategy. Peer analysis of Sio Gene could also be used in its relative valuation, which is a method of valuing Sio Gene by comparing valuation metrics with similar companies.

Peers

Sio Gene Related Equities

SRZNSurrozen   19.37   
0%
100.0%
ALGSAligos Therapeutics   10.96   
0%
56.0%
MNPRMonopar Therapeutics   8.84   
0%
45.0%
VINCVincerx Pharma   7.69   
0%
39.0%
CTMXCytomX Therapeutics   3.92   
0%
20.0%
VCNXVaccinex   2.44   
0%
12.0%
ASMBAssembly Biosciences   1.25   
0%
6.0%
RZLTRezolute   1.00   
0%
5.0%
XOMAXOMA Corp   0.84   
0%
4.0%
NUVBNuvation Bio   0.35   
0%
1.0%
MOLNMolecular Partners   0.17   
1.0%
0%
TARAProtara Therapeutics   0.99   
5.0%
0%
SABSSAB Biotherapeutics   1.02   
5.0%
0%
TPSTTempest Therapeutics   1.04   
5.0%
0%
TILInstil Bio   9.39   
48.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in Sio Stock

If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios